3-dimensional structures to enhance cell therapy and engineer contractile tissue

Asian Cardiovascular and Thoracic Annals

Volumn 18, Issue 2, 2010, Pages 188-198

  Schussler, Olivier ^a,b   Chachques, Juan C ^a   Mesana, Thierry G ^b   Suuronen, Erik J ^a   Lecarpentier, Yves ^c,d   Ruel, Marc ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c BICÊTRE HOSPITAL   (France)

^d Meaux Hospital   (France)

Author keywords

Cell transplantation; Heart failure; Myocardial infarction; Tissue engineering

Indexed keywords

CELL ADHESION MOLECULE; COLLAGEN; COLLAGEN FIBER; MEMBRANE RECEPTOR;

ANGIOGENESIS; APOPTOSIS; BIOCOMPATIBILITY; BONE MARROW CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL HOMING; CELL INTERACTION; CELL MIGRATION; CELL MOTILITY; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CELL THERAPY; CELL TRANSPLANTATION; CROSS LINKING; ELECTROSTIMULATION; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; ENGRAFTMENT; EXTRACELLULAR MATRIX; HEART FAILURE; HUMAN; MESENCHYME CELL; MUSCLE FIBER CONTRACTION; MYOBLAST; MYOCARDIAL HIBERNATION; NONHUMAN; PLURIPOTENT STEM CELL; POSITRON EMISSION TOMOGRAPHY; REVIEW; SHEAR STRESS; STEM CELL; THREE DIMENSIONAL IMAGING; TISSUE ENGINEERING;

ANIMALS; CELL TRANSPLANTATION; HUMANS; MYOCARDIAL INFARCTION; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 77951070113     PISSN: 02184923     EISSN: None     Source Type: Journal    
DOI: 10.1177/0218492310361531     Document Type: Review

References (108)

1. Chien KR, Domian IJ, Parker KK. Cardiogenesis and the complex biology of regenerative cardiovascular medicine. Science 2008;322(5907): 1494-1497
2. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S, et al. Evidence for cardiomyocyte renewal in humans. Science 2009;324(5923): 98-102.
3. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364(9429): 141-148 (Pubitemid 38891685)
4. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-1221 (Pubitemid 44427445)
5. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006;355:1199-1209 (Pubitemid 44427444)
6. Assmus B, Honold J, Schachinger V, Britten MB, Fischer-Rasokat U, Lehmann R, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006;355:1222-1232 (Pubitemid 44427446)
7. Passier R, van Laake LW, Mummery CL. Stem-cell-based therapy and lessons from the heart. Nature 2008;453(7193): 322-329
8. Menasche P. Current status and future prospects for cell transplantation to prevent congestive heart failure. Semin Thorac Cardiovasc Surg 2008;20:131-137
9. Nadal-Ginard B, Fuster V. Myocardial cell therapy at the crossroads. Nat Clin Pract Cardiovasc Med 2007;4:1.
10. Cheng AS, Yau TM. Paracrine effects of cell transplantation: strategies to augment the efficacy of cell therapies. Semin Thorac Cardiovasc Surg 2008;20:94-101.
11. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003;9:1195-1201 (Pubitemid 37173705)
12. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008;103:1204-1219
13. Tomescot A, Leschik J, Bellamy V, Dubois G, Messas E, Bruvenal P, et al. Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats. Stem Cells 2007;25:2200-2205 (Pubitemid 47480478)
14. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-872 (Pubitemid 350138099)
15. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318(5858): 1917-1920
16. Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hamalainen R, et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009;458(7239):766-770
17. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009;458(7239):771-775
18. Leschik J, Stefanovic S, Brinon B, Puceat M. Cardiac commitment of primate embryonic stem cells. Nat Protoc 2008;3:1381-1387
19. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007;25:1015-1024 (Pubitemid 47517637)
20. Van Laake LW, Passier R, Doevendans PA, Mummery CL. Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ Res 2008;102:1008-1010 (Pubitemid 351667854)
21. Yasuda T, Weisel RD, Kiani C, Mickle DA, Maganti M, Li RK. Quantitative analysis of survival of transplanted smooth muscle cells with real-time polymerase chain reaction. J Thorac Cardiovasc Surg 2005;129:904-911 (Pubitemid 40487896)
22. Sondergaard CS, Bonde J, Dagnaes-Hansen F, Muskheli V, Fugate JA, Dupras SK, et al. Minimal engraftment of human CD34+ cells mobilized from healthy donors in the infarcted heart of athymic nude rats. Stem Cells Dev 2009;18:845-856
23. Fukushima S, Varela-Carver A, Coppen SR, Yamahara K, Felkin LE, Lee J, et al. Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation 2007;115:2254-2261 (Pubitemid 46685893)
24. Hudson W, Collins MC, deFreitas D, Sun YS, Muller-Borer B, Kypson AP. Beating and arrested intramyocardial injections are associated with significant mechanical loss: implications for cardiac cell transplantation. J Surg Res 2007;142:263-267
25. Li SH, Lai TY, Sun Z, Han M, Moriyama E, Wilson B, et al. Tracking cardiac engraftment and distribution of implanted bone marrow cells: comparing intra-aortic, intravenous, and intramyocardial delivery. J Thorac Cardiovasc Surg 2009;137:1225-1233 e1.
26. Zang Y, Thorn S, Dasilva JN, Lamoureux M, DeKemp RA, Beanlands RS, et al. Collagen-based matrices improve the delivery of transplanted circulating progenitor cells: development and demonstartions by ex vivo radionuclide cell labeling and in vivo tracking with positron emission tomography. Cardiovasc Imaging 2008;1:197-204.
27. Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B, et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005;111:2198-2202 (Pubitemid 40632435)
28. von Wnuck Lipinski K, Keul P, Ferri N, Ferri N, Lucke S, Heusch G, et al. Integrin-mediated transcriptional activation of inhibitor of apoptosis proteins protects smooth muscle cells against apoptosis induced by degraded collagen. Circ Res 2006;98:1490-1497 (Pubitemid 44297071)
29. Halbach M, Pfannkuche K, Pillekamp F, Ziomka A, Hannes T, Reppel M, et al. Electrophysiological maturation and integration of murine fetal cardiomyocytes after transplantation. Circ Res 2007;101:484-492 (Pubitemid 47347879)
30. Cherqui S, Kingdon KM, Thorpe C, Kurian SM, Salomon DR. Lentiviral gene delivery of vMIP-II to transplanted endothelial cells and endothelial progenitors is proangiogenic in vivo. Mol Ther 2007;15:1264-1272 (Pubitemid 46965322)
31. Macchiarelli G, Ohtani O. Endomysium in left ventricle. Heart 2001;86:416.
32. Lindsey ML, Mann DL, Entman ML, Spinale FG. Extracellular matrix remodeling following myocardial injury. Ann Med 2003;35:316-326 (Pubitemid 37013672)
33. Xiao Q, Luo Z, Pepe AE, Margariti A, Zeng L, Xu Q. Embryonic Stem Cell Differentiation into Smooth Muscle Cells is Mediated by Nox4-Produced H2O2. Am J Physiol Cell Physiol 2008;296:C711-23.
34. Au HT, Cheng I, Chowdhury MF, Radisic M. Interactive effects of surface topography and pulsatile electrical field stimulation on orientation and elongation of fibroblasts and cardiomyocytes. Biomaterials 2007;28:4277-4293 (Pubitemid 47212400)
35. Engler AJ, Griffin MA, Sen S, Bonnemann CG, Sweeney HL, Discher DE. Myotubes differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff microenvironments. J Cell Biol 2004;166:877-887 (Pubitemid 39249838)
36. Engler AJ, Carag-Krieger C, Johnson CP, Raab M, Tang HY, Speicher DW, et al. Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating. J Cell Sci 2008;121(Pt 22): 3794-3802
37. Badie N, Bursac N. Novel micropatterned cardiac cell cultures with realistic ventricular microstructure. Biophys J 2009;96:3873-3885
38. Valencik ML, Zhang D, Punske B, Hu P, McDonald JA, Litwin SE. Integrin activation in the heart: a link between electrical and contractile dysfunction? Circ Res 2006;99:1403-1410
39. Suuronen EJ, Veinot JP, Wong S, Kapila V, Price J, Griffith M, et al. Tissue-engineered injectable collagen-based matrices for improved cell delivery and vascularization of ischemic tissue using CD133+ progenitors expanded from the peripheral blood. Circulation 2006;114(Suppl I): 138-144
40. Hamdi H, Furuta A, Bellamy V, Bel A, Puymirat E, Peyrard S, et al. Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison. Ann Thorac Surg 2009;87:1196-1203
41. Whittaker P, Muller-Ehmsen J, Dow JS, Kedes LH, Kloner RA. Development of abnormal tissue architecture in transplanted neonatal rat myocytes. Ann Thorac Surg 2003;75:1450-1456 (Pubitemid 36515219)
42. Engler A, Bacakova L, Newman C, Hategan A, Griffin M, Discher D. Substrate compliance versus ligand density in cell on gel responses. Biophys J 2004;86:617-628 (Pubitemid 38067491)
43. Geisse NA, Sheehy SP, Parker KK. Control of myocyte remodeling in vitro with engineered substrates. In Vitro Cell Dev Biol Anim 2009;45:343-350
44. Schussler O, Coirault C, Louis-Tisserand M, Al-Chare W, Oliviero P, Menard C, et al. Use of arginine-glycine-aspartic acid adhesion peptides coupled with a new collagen scaffold to engineer a myocardium-like tissue graft. Nat Clin Pract Cardiovasc Med 2009;6:240-249
45. Radisic M, Park H, Shing H, Consi T, Schoen FJ, Langer R, et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A 2004;101:18129-18134 (Pubitemid 40054085)
46. Radisic M, Park H, Gerecht S, Cannizzaro C, Langer R, Vunjak-Novakovic G. Biomimetic approach to cardiac tissue engineering. Philos Trans R Soc Lond B Biol Sci 2007;362:1357-1368 (Pubitemid 47195028)
47. Tuxworth Jr WJ, Shiraishi H, Moschella PC, Yamane K, McDermott PJ, Kuppuswamy D. Translational activation of 5′-TOP mRNA in pressure overload myocardium. Basic Res Cardiol 2008;103:41-53. (Pubitemid 350286466)
48. Radisic M, Yang L, Boublik J, Cohen RJ, Langer R, Freed LE, et al. Medium perfusion enables engineering of compact and contractile cardiac tissue. Am J Physiol Heart Circ Physiol 2004;286:H507-16.
49. Shen YH, Shoichet MS, Radisic M. Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells. Acta Biomater 2008;4:477-489
50. Suuronen EJ, Cao X, Melhuish A, Zhang P, Mckee D, Li F, et al. Cell-based angiogenic therapy without cell transplantation: enhanced engraftment of endogenous circulating progenitor cells using an acellular matrix-bound ligand. Faseb J 2009;23:1447-1458
51. Callegari A, Bollini S, Iop L, Chiavegato A, Torregrossa G, Pozzobon M, et al. Neovascularization induced by porous collagen scaffold implanted on intact and cryoinjured rat hearts. Biomaterials 2007;28:5449-5461 (Pubitemid 47603197)
52. Eschenhagen T, Fink C, Remmers U, Scholz H, Wattchow J, Weil J, et al. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. Faseb J 1997;11:683-694 (Pubitemid 27318285)
53. Eschenhagen T, Didie M, Munzel F, Schubert P, Schneiderbanger K, Zimmermann WH. 3D engineered heart tissue for replacement therapy. Basic Res Cardiol 2002;97;(Suppl 1): 146-152 (Pubitemid 34624773)
54. Severs NJ, Coppen SR, Dupont E, Yeh HI, Ko YS, Matsushita T. Gap junction alterations in human cardiac disease [Review]. Cardiovasc Res 2004;62:368-377 (Pubitemid 38496549)
55. Pijnappels DA, Schalij MJ, Ramkisoensing AA, van Tuyn J, de Vries AA, van der Laarse A, et al. Forced alignment of mesenchymal stem cells undergoing cardiomyogenic differentiation affects functional integration with cardiomyocyte cultures. Circ Res 2008;103:167-176
56. Kutschka I, Chen IY, Kofidis T, Arai T, von Degenfeld G, Sheikh AY, et al. Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation 2006;114(Suppl I): 167-173 (Pubitemid 44297146)
57. Zimmermann WH, Melnychenko I, Wasmeier G, Didie M, Naito H, Nixdorff U, et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 2006;12:452-458
58. Guo XM, Wang CY, Tian XC, Yang X. Engineering cardiac tissue from embryonic stem cells. Methods Enzymol 2006;420:316-338 (Pubitemid 44856797)
59. Badylak SF, Gilbert TW. Immune response to biologic scaffold materials [Review]. Semin Immunol 2008;20:109-116
60. Badylak SF. Xenogeneic extracellular matrix as a scaffold for tissue reconstruction [Review]. Transpl Immunol 2004;12:367-377
61. Yildirim Y, Naito H, Didie M, Karikkineth BC, Biermann D, Eschenhagen T, et al. Development of a biological ventricular assist device: preliminary data from a small animal model. Circulation 2007;116(Suppl I): 16-23. (Pubitemid 47480765)
62. Reinecke H, Minami E, Zhu WZ, Laflamme MA. Cardiogenic differentiation and transdifferentiation of progenitor cells. Circ Res 2008;103:1058-1071
63. Kubo H, Jaleel N, Kumarapeli A, Berretta RM, Bratinov G, Shan X, et al. Increased cardiac myocyte progenitors in failing human hearts. Circulation 2008;118:649-657
64. Suuronen EJ, Muzakare L, Doillon CJ, Kapila V, Li F, Ruel M, et al. Promotion of angiogenesis in tissue engineering: developing multicellular matrices with multiple capacities. Int J Artif Organs 2006;29:1148-1157 (Pubitemid 46165203)
65. Suuronen EJ, Kuraitis D, Ruel M. Improving cell engraftment with tissue engineering. Semin Thorac Cardiovasc Surg 2008;20:110-114
66. Chai C, Leong KW. Biomaterials approach to expand and direct differentiation of stem cells. Mol Ther 2007;15:467-480 (Pubitemid 46306589)
67. Liu WF, Chen CS. Engineering biomaterials to control cell function [Review]. Material Today 2005;8:28-35.
68. Vogel V, Sheetz M. Local force and geometry sensing regulate cell functions [Review]. Nat Rev Mol Cell Biol 2006;7:265-275
69. Kovacic-Milivojevic B, Roediger F, Almeida EA, Damsky CH, Gardner DG, Ilic D. Focal adhesion kinase and p130Cas mediate both sarcomeric organization and activation of genes associated with cardiac myocyte hypertrophy. Mol Biol Cell 2001;12:2290-2307 (Pubitemid 33051957)
70. Noutsias M, Fechner H, de Jonge H, Wang X, Dekkers D, Houtsmuller AB, et al. Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections. Circulation 2001;104:275-280
71. Samarel AM. Costameres, focal adhesions, and cardiomyocyte mechanotransduction [Review]. Am J Physiol Heart Circ Physiol 2005;289:H2291-301.
72. Katsumi A, Orr AW, Tzima E, Schwartz MA. Integrins in mechanotransduction. J Biol Chem 2004;279:12001-12004
73. Kuppuswamy D. Importance of integrin signaling in myocyte growth and survival. Circ Res 2002;90:1240-1242 (Pubitemid 34787404)
74. Parker KK, Tan J, Chen CS, Tung L. Myofibrillar architecture in engineered cardiac myocytes. Circ Res 2008;103:340-342
75. Ehler E, Fowler VM, Perriard JC. Myofibrillogenesis in the developing chicken heart: role of actin isoforms and of the pointed end actin capping protein tropomodulin during thin filament assembly. Dev Dyn 2004;229:745-755 (Pubitemid 38429103)
76. Leor J, Amsalem Y, Cohen S. Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacol Ther 2005;105:151-163 (Pubitemid 40163987)
77. Zimmermann WH, Didie M, Doker S, Melnychenko I, Naito H, Rogge C, et al. Heart muscle engineering: an update on cardiac muscle replacement therapy. Cardiovasc Res 2006;71:419-429 (Pubitemid 44107857)
78. Akhyari P, Kamiya H, Haverich A, Karck M, Lichtenberg A. Myocardial tissue engineering: the extracellular matrix [Review]. Eur J Cardiothorac Surg 2008;34:229-241
79. Engelmayr GC Jr, Cheng M, Bettinger CJ, Borenstein JT, Langer R, Freed LE. Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat Mater 2008;7:1003-1010
80. Caspi O, Lesman A, Basevitch Y, Gepstein A, Arbel G, Habib IH, et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res 2007;100:263-272 (Pubitemid 46208727)
81. Narmoneva DA, Vukmirovic R, Davis ME, Kamm RD, Lee RT. Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration. Circulation 2004;110:962-968 (Pubitemid 39136214)
82. Shimizu T, Yamato M, Isoi Y, Akutsu T, Setomaru T, Abe K, et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 2002;90:e40.
83. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008;14:213-221
84. Badylak SF. The extracellular matrix as a biologic scaffold material [Review]. Biomaterials 2007;28:3587-3593
85. Ashley RA, Palmer BW, Schultz AD, Woodson BW, Roth CC, Routh JC, et al. Leukocyte inflammatory response in a rat urinary bladder regeneration model using porcine small intestinal submucosa scaffold. Tissue Eng Part A 2009;15:3241-3246
86. Robinson KA, Li J, Mathison M, Redkar A, Cui J, Chronos NA, et al. Extracellular matrix scaffold for cardiac repair. Circulation 2005;112(Suppl I): 135-143 (Pubitemid 41266665)
87. Ota T, Gilbert TW, Schwartzman D, McTiernan CF, Kitajima T, Ito Y, et al. A fusion protein of hepatocyte growth factor enhances reconstruction of myocardium in a cardiac patch derived from porcine urinary bladder matrix. J Thorac Cardiovasc Surg 2008;136:1309-1317
88. Shi J, Dong N, Sun Z. Impact of immobilized RGD peptides on cell attachment of decellularized valve scaffolds. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2008;25:388-392
89. Ye X, Zhao Q, Sun X, Li H. Enhancement of mesenchymal stem cell attachment to decellularized porcine aortic valve scaffold by in vitro coating with antibody against CD90: a preliminary study on antibody-modified tissue-engineered heart valve. Tissue Eng Part A 2009;15:1-11.
90. Kofidis T, Akhyari P, Wachsmann B, Mueller-Stahl K, Boublik J, Ruhparwar A, et al. Clinically established hemostatic scaffold (tissue fleece) as biomatrix in tissue- and organ-engineering research. Tissue Eng 2003;9:517-523 (Pubitemid 36736134)
91. Gaballa MA, Sunkomat JN, Thai H, Morkin E, Ewy G, Goldman S. Grafting an acellular 3-dimensional collagen scaffold onto a non-transmural infarcted myocardium induces neo-angiogenesis and reduces cardiac remodeling. J Heart Lung Transplant 2006;25:946-954 (Pubitemid 44144592)
92. Kofidis T, de Bruin JL, Hoyt G, Lebl DR, Tanaka M, Yamane T, et al. Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. J Thorac Cardiovasc Surg 2004;128:571-578 (Pubitemid 39278391)
93. Cortes-Morichetti M, Frati G, Schussler O, Van Huyen JP, Lauret E, Genovese JA, et al. Association between a cell-seeded collagen matrix and cellular cardiomyoplasty for myocardial support and regeneration. Tissue Eng 2007;13:2681-2687 (Pubitemid 350076754)
94. Chachques JC, Trainini JC, Lago N, Masoli OH, Barisani JL, Cortes-Morichetti M, et al. Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM clinical trial): one year follow-up. Cell Transplant 2007;16:927-934 (Pubitemid 351448610)
95. Satake S, Kuzuya M, Ramos MA, Kanda S, Iguchi A. Angiogenic stimuli are essential for survival of vascular endothelial cells in three-dimensional collagen lattice. Biochem Biophys Res Commun 1998;244:642-646 (Pubitemid 28418121)
96. Ilan N, Mahooti S, Madri JA. Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. J Cell Sci 1998;111:3621-3631 (Pubitemid 29017560)
97. Goto F, Goto K, Weindel K, Folkman J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 1993;69:508-517 (Pubitemid 24004487)
98. Ranta V, Mikkola T, Ylikorkala O, Viinikka L, Orpana A. Reduced viability of human vascular endothelial cells cultured on Matrigel. J Cell Physiol 1998;176:92-98 (Pubitemid 28277199)
99. Souren JE, Schneijdenberg C, Verkleij AJ, Van Wijk R. Factors controlling the rhythmic contraction of collagen gels by neonatal heart cells. In Vitro Cell Dev Biol 1992;28A:199-204.
100. Akhyari P, Fedak PW, Weisel RD, Lee TY, Verma S, Mickle DA, et al. Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts. Circulation 2002;106(Suppl I): 137-142
101. Zimmermann WH, Didie M, Wasmeier GH, Nixdorff U, Hess A, Melnychenko I, et al. Cardiac grafting of engineered heart tissue in syngenic rats. Circulation 2002;106(Suppl I): 151-157
102. Naito H, Melnychenko I, Didie M, Schneiderbanger K, Schubert P, Rosenkranz S, et al. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 2006;114(Suppl I): 72-78
103. Kruger M, Sachse C, Zimmermann WH, Eschenhagen T, Klede S, Linke WA. Thyroid hormone regulates developmental titin isoform transitions via the phosphatidylinositol-3-kinase/AKT pathway. Circ Res 2008;102:439-447 (Pubitemid 351651105)
104. Balasubramanian S, Kuppuswamy D. RGD-containing peptides activate S6K1 through beta3 integrin in adult cardiac muscle cells. J Biol Chem 2003;278:42214-42224 (Pubitemid 37310488)
105. Sarin V, Gaffin RD, Meininger GA, Muthuchamy M. Arginine-glycine-aspartic acid (RGD)-containing peptides inhibit the force production of mouse papillary muscle bundles via alpha 5 beta 1 integrin. J Physiol 2005;564:603-617 (Pubitemid 40585057)
106. Levenberg S, Rouwkema J, Macdonald M, Garfein ES, Kohane DS, Darland DC, et al. Engineering vascularized skeletal muscle tissue. Nat Biotechnol 2005;23:879-884 (Pubitemid 43093132)
107. Schussler O, Coirault C, Louis-Tisserand M, El-Chare W, Oliviero P, Ménard C, et al. Abstract 425: RGD-coupling to collagen scaffold improves cardiomyocyte viability and contractility: new possibilities for cardiac tissue engineering. Circulation 2007;116(Suppl II): 70.
108. Biancone L, Cantaluppi V, Duo D, Deregibus MC, Torre C, Camussi G. Role of L-selectin in the vascular homing of peripheral blood-derived endothelial progenitor cells. J Immunol 2004;173:5268-5274 (Pubitemid 39387810)